CHANTER syndrome
Evidence-based neurology checklist on chanter syndrome: Provoking agents Fentanyl Hydromorphone Heroin Pathogenetic mechanisms Clinical features Paediatric opioid-use-associated neurotoxicity with cerebellar edema (POUNCE Differential diagnosis Magnetic resonance imaging (MRI) Pathological…
Provoking agents
- Fentanyl
- Hydromorphone
- Heroin
Pathogenetic mechanisms
Clinical features
Paediatric opioid-use-associated neurotoxicity with cerebellar edema (POUNCE
Differential diagnosis
Magnetic resonance imaging (MRI)
Pathological features
Other investigations
Treatment
Possible outcomes
Acronym
References
- Jasne AS, Alsherbini KH, Smith MS, Pandhi A, Vagal A, Kanter D. Cerebellar hippocampal and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome. Neurocrit Care 2019; 31:288-296.
- Mallikarjun KS, Parsons MS, Nigogosyan Z, Goyal MS, Eldaya RW. Neuroimaging findings in CHANTER syndrome: a case series. AJNR 2022; 43:1136-1141.
- Atac MF, Vilanilam GK, Damalcheruvu PR, Pandey I, Vattoth S. Cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome in the setting of opioid and phencyclidine use. Radiol Case Rep 2023; 18:3496-3500.
- Zhou YMJ, Shah M, Fayngersh A. A case of cerebellar hippocampal and basal nuclei transient edema with restricted diffusion syndrome with poor clinical outcome. Cureus 2022; 14:e22767.
- Sotiropoulos MG, Harrison DS, Zusman BE, Puccetti MV, Molyneaux BJ. CHANTER syndrome: an under-recognized cause of reversible hydrocephalus after opioid overdose. Neurol Sci 2024 (Online ahead of print).
- And 1 more. Subscribe to see the full list
